JONATHON VILLARREAL: Open Payments
NPI 1013645381 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 27 payments from 10 companies in 2025. Trend: 2023 $135 · 2024 $316 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $167 |
| Merck Sharp & Dohme LLC | 3 | $86 |
| Amgen Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $45 |
| PFIZER INC. | 1 | $29 |
| Viatris Specialty LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $13 |
Products named: VRAYLAR, WINREVAIR, EVENITY, Auvelity, Ozempic, NURTEC ODT, YUPELRI, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
